 Home > Medical News > Latest Medical News > The clinical application of ASKC852 tablets of Osaikang was undertaken by CDE

The clinical application of ASKC852 tablets of Osaikang was undertaken by CDE

 Last Update: 2021-05-09
 Source: Internet
 Author: User

Tags

tapazole drug

systemic bacterial infection

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 23, Osaikang declared a new drug clinical application for the first class of new drug ASKC852 tablets, which was undertaken by CDE, which is a small molecule immunomodulatory drug.

Figure 1: The new drug that Osaikang has declared for clinical use this time

Source: CDE official website

According to data, ASKC852 is a new class 1 drug jointly developed by Aosaekang and Shanghai WuXi AppTec.

In the earlier pharmacodynamic experiment, ASKC852 single agent can have a significant inhibitory effect on tumors, and when combined with PD-L1 monoclonal antibody, it can also produce excellent synergistic effects, making PD-L1 monoclonal antibody anti-tumor effect Significantly improved.

Figure 2: New drugs declared and under review by Osaikang this year

Source: Meinenet MED2.

Since 2021, Osaikang has applied for two new drugs.

It is reported that dexlansoprazole is a proton pump inhibitor and is the R-isomer of lansoprazole.

Table 1: Part of the latest developments of Aosaiken's Class 1 and Class 2 new drugs

Source: Meinenet MED2.

Aosaikang is currently a leading domestic enterprise in the subdivision of anti-peptic ulcer proton pump inhibitor injection products.

Source: Minet database, CDE official website

The review data statistics are as of April 26, if there are any errors or omissions, please correct me.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.